PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c

Jie Zhu1, Hao Ding1, Xiaohong Wang1

  • 1Department of General Surgery, Huadong Hospital Shanghai 200040.

Insights

Poly(A)-binding protein 1 (PABPC1) acts as an oncogene in gastric cancer, promoting tumor growth and survival. Its upregulation in gastric carcinoma tissues correlates with poor patient prognosis and is linked to miR-34c regulation.

Area of Science:

  • Molecular Oncology
  • Gastrointestinal Cancer Research

Background:

  • Gastric carcinoma is a leading cause of cancer death globally, with its underlying mechanisms incompletely understood.
  • Poly(A)-binding protein 1 (PABPC1) is crucial for mRNA processing, including translation and decay, and has been implicated in carcinogenesis.

Purpose of the Study:

  • To investigate the role of PABPC1 as an oncogenic protein in gastric carcinoma.
  • To elucidate the functional mechanisms by which PABPC1 influences gastric cancer progression and survival.

Main Methods:

  • Analysis of PABPC1 expression levels in gastric carcinoma tissues.
  • In vitro and in vivo studies to assess the impact of PABPC1 on cell proliferation, transformation, and apoptosis.
  • Investigation of the regulatory relationship between PABPC1 and microRNA-34c (miR-34c).

Main Results:

  • PABPC1 expression is significantly upregulated in gastric carcinoma tissues.
  • High PABPC1 expression is associated with poor patient survival.
  • PABPC1 knockdown inhibits gastric cancer cell proliferation and transformation, and induces apoptosis by modulating pro- and anti-apoptotic proteins.
  • PABPC1 directly targets and regulates miR-34c, which is essential for PABPC1's oncogenic functions.

Conclusions:

  • PABPC1 functions as an oncogenic protein in gastric carcinoma.
  • PABPC1 promotes gastric cancer cell growth and survival, partly through its regulation of miR-34c.
  • Targeting PABPC1 may represent a therapeutic strategy for gastric cancer.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K